Skip to content

← All news

Markets

Raymond James raises Rapport Therapeutics price target on bipolar catalyst potential

1 source ·2 articles ·Aug 17, 11:06 UTC Rapport Therapeutics

Covered by 1 outlet

All coverage · 2 articles

Investing.com Canada ·Aug 17, 11:06 UTC

Raymond James raises Rapport Therapeutics price target on bipolar catalyst potential

Investing.com News ·Aug 17, 11:04 UTC

Raymond James raises Rapport Therapeutics price target on bipolar catalyst potential